Over a 6-year period, 24 extended-spectrum -lactamase (ESBL)-producing isolates of Pseudomonas aeruginosa were collected from 18 patients living in a nursing home. These isolates had a delayed development of a red pigment and exhibited a similar antibiotype (resistance to all -lactams except for imipenem and to gentamicin, tobramycin, netilmicin, ciprofloxacin, and rifampin) associated with the production of the TEM-21 -lactamase and a type II 3-N-aminoglycoside acetyltransferase [AAC(3)-II] enzyme. Surprisingly, serotyping showed that these isolates belonged to four successive serotypes (P2, P16, P1, and PME), although molecular typing by PCR methods and pulsed-field gel electrophoresis yielded identical or similar profiles. Moreover, in all isolates the bla TEM-21 gene was part of a chromosomally located Tn801 transposon truncated by an IS6100 element inserted within the resolvase gene, and the aac(3)-II gene was adjacent to this structure. During the same period, 17 ESBL-producing isolates of enterobacteria were also collected from 10 of these patients. These isolates harbored a similar large plasmid that contained the bla TEM-21 and the aac(3)-II genes and that conferred additional resistance to sulfonamides and chloramphenicol, as well as to kanamycin, tobramycin, netilmicin, and amikacin, conveyed by an AAC(6)-I enzyme. The bla TEM-21 gene was part of the Tn801 transposon disrupted by IS4321. Thus, a single clone of P. aeruginosa that had undergone a progressive genetic drift associated with a change in serotype appeared to be responsible for an outbreak of nosocomial infections in a nursing home. This strain has probably acquired the bla TEM-21 -encoding plasmid that was epidemic among the enterobacteria at the institution, followed by chromosomal integration and genomic reorganization.Pseudomonas aeruginosa is a saprophytic organism widespread in nature, particularly in moist environments (water, soil, plants, and sewage). This bacterial species is endowed with only a weak pathogenic potential in immunocompetent persons (2, 17, 21, 23) but can cause severe and even fatal infections in patients with impaired specific or nonspecific defense systems (40). Thus, P. aeruginosa is rarely involved in community-acquired infections, while it is responsible for a wide range of hospital-acquired infections, such as pneumonia, urinary tract infections (UTIs), and bacteremia. Moreover, a series of outbreaks due to this important and frequent nosocomial pathogen has been reported in hospital intensive care, burn wound, and cancer units (6, 13, 42). In contrast, little has been reported on P. aeruginosa-induced infections in long-term-care facilities, including nursing homes; and most of the studies that have reported such infections have described sporadic cases rather than outbreaks (16,22,44).Linked to its nosocomial status, P. aeruginosa is intrinsically resistant to most antimicrobials. In addition, resistance to the main active agents, i.e., -lactams and aminoglycosides, by gene acquisition is common. However...